These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 2253080)
1. Comparison of the in-vivo and in-vitro response to ragweed immunotherapy in children and adults with ragweed-induced rhinitis. Hedlin G; Silber G; Naclerio R; Proud D; Lamas AM; Eggleston P; Adkinson NF Clin Exp Allergy; 1990 Sep; 20(5):491-500. PubMed ID: 2253080 [TBL] [Abstract][Full Text] [Related]
2. A double-blind study of the discontinuation of ragweed immunotherapy. Naclerio RM; Proud D; Moylan B; Balcer S; Freidhoff L; Kagey-Sobotka A; Lichtenstein LM; Creticos PS; Hamilton RG; Norman PS J Allergy Clin Immunol; 1997 Sep; 100(3):293-300. PubMed ID: 9314339 [TBL] [Abstract][Full Text] [Related]
3. Attenuation of allergen sensitivity early in the course of ragweed immunotherapy. Hedlin G; Silber G; Schieken L; Naclerio R; Proud D; Eggleston P; Adkinson NF J Allergy Clin Immunol; 1989 Sep; 84(3):390-9. PubMed ID: 2476472 [TBL] [Abstract][Full Text] [Related]
4. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. Creticos PS; Schroeder JT; Hamilton RG; Balcer-Whaley SL; Khattignavong AP; Lindblad R; Li H; Coffman R; Seyfert V; Eiden JJ; Broide D; N Engl J Med; 2006 Oct; 355(14):1445-55. PubMed ID: 17021320 [TBL] [Abstract][Full Text] [Related]
5. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis. Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684 [TBL] [Abstract][Full Text] [Related]
6. Seasonal changes in IgE antibodies and their relationship to IgG antibodies during immunotherapy for ragweed hay fever. Yunginger JW; Gleich GJ J Clin Invest; 1973 May; 52(5):1268-75. PubMed ID: 4735589 [TBL] [Abstract][Full Text] [Related]
7. Immunologic effects of encapsulated short ragweed extract: a potent new agent for oral immunotherapy. Litwin A; Flanagan M; Entis G; Gottschlich G; Esch R; Gartside P; Michael JG Ann Allergy Asthma Immunol; 1996 Aug; 77(2):132-8. PubMed ID: 8760779 [TBL] [Abstract][Full Text] [Related]
8. Controlled evaluation of allergoid in the immunotherapy of ragweed hay fever. Norman PS; Lichtenstein LM; Kagey-Sobotka A; Marsh DG J Allergy Clin Immunol; 1982 Oct; 70(4):248-60. PubMed ID: 6181113 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of oral immunotherapy with short ragweed extract. Van Deusen MA; Angelini BL; Cordoro KM; Seiler BA; Wood L; Skoner DP Ann Allergy Asthma Immunol; 1997 Jun; 78(6):573-80. PubMed ID: 9207721 [TBL] [Abstract][Full Text] [Related]